This printed article is located at http://cordlife.listedcompany.com/competitive_strengths.html
We are one of the first private cord blood banks in Asia. Our processing facilities are located in Singapore and Hong Kong and we currently have stored in excess of 40,000 cord blood units in these two locations.
We have displayed our clinical leadership as we believe we are one of the first private cord blood banks in Singapore and amongst the first in Hong Kong to have issued cord blood units stored with us for transplants and other therapeutic use. We continue to engage the medical community in driving the medical utility of cord blood. For instance, we were the first private cord blood bank to release cord blood units for the treatment of cerebral palsy in Singapore.
Since 2005, Cordlife Group Limited has been accredited by AABB (formerly known as American Association of Blood Banks), an organisation widely recognised as the gold standard in the industry. Our Hong Kong facility has been certified ISO:9001 since 2006 and was accredited by AABB in since 2011. By late 2015, the Singapore facility achieved accreditation from FACT-Netcord, placing the Group as one of the six international private cord blood banks that hold accreditations by two world-class standards.
We were one of the first to adopt an automated processing system in Singapore and Hong Kong and we are constantly seeking to improve our services through the use of technology.
We have a strong and dedicated management team led by our Executive Director and Chief Executive Officer who oversees the overall business strategy, corporate development and business growth of our Group. He is in turn supported by our Executive Officers who have been in our Company in various positions before assuming their current leadership roles and such cross functional experiences have given them an in-depth knowledge of the industry and our Group.
We believe that our track record both as a pioneer in the cord blood banking industry within Asia and our growth over the last ten years, is testament to our deep understanding of the market forces, regulations and competitive environment of the cord blood banking industry, thus enabling us to remain a market leader in the regions in which we operate in.
We have a well-established brand and extensive distribution networks that provide us with significant leverage in introducing other tissue banking products and services in the future.
In particular, we have entered into arrangements with the major private hospitals and several clinics in Singapore and Hong Kong to actively educate expectant mothers on our services.